Aryl hydrocarbon receptor and bilirubin as therapeutic target for ICH
芳烃受体和胆红素作为脑出血的治疗靶点
基本信息
- 批准号:10299427
- 负责人:
- 金额:$ 46.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:ABCB1 geneAffectAgeAgonistAnimalsAnti-Inflammatory AgentsAntioxidantsAryl Hydrocarbon ReceptorBilirubinBindingBiologicalBloodBrainBrain InjuriesCerebral hemisphere hemorrhageClinicalCytoprotectionCytosolDNADataDrug Metabolic DetoxicationErythrocytesErythrophagocytosisExcisionExcretory functionExtracellular SpaceFunctional disorderGenesGenetic TranscriptionGlutathione S-TransferaseHealthHematomaHemeHemoglobinHemorrhageHomeostasisIn VitroInflammationInflammatoryInflammatory ResponseInjuryKnockout MiceMediatingMembraneMicrogliaMolecularNeurologicNeurological outcomeNuclear TranslocationNucleic AcidsPathway interactionsPhagocytesPhagocytosisPhenotypePigmentsPlayPrecipitationProcessProductionProteinsPumpReceptor ActivationRecoveryResearchResolutionRoleSmall Interfering RNASolubilitySulforaphaneTherapeuticactivating transcription factorbasebrain cellbrain repaircell injuryheme oxygenase-1in vivoinhibitor/antagonistinjuredmacrophagemouse modelneurological recoverynew therapeutic targetnuclear factor-erythroid 2preservationpreventrepairedresponserestorationsextherapeutic targettranscription factorwater solubility
项目摘要
After intracerebral hemorrhage (ICH), phago(endo)cytosis of hematoma components [erythrocytes (RBC),
hemoglobin (Hb) and heme], by microglia/macrophages (MMΦ) is essential for removal/detoxification of the
hematoma, resolution of inflammation, and restoration of brain homeostasis for optimal neurological recovery.
Thus, strategies for protecting MMΦ from injury during engulfment of toxic hematoma components is critical for
the efficiency of MMΦ in clearing the hematoma after ICH.
Upon engulfment of RBC/Hb/heme from the hematoma, MMΦ express heme oxygenase 1 (HO1; encoded by
Hmox1), which catabolizes heme to produce large amounts of bilirubin (BrB) within MMΦ. Normally BrB is a
beneficial and potent antioxidant; however, when intracellular BrB accumulates to very high concentrations, it
may reversibly inhibit HO1 activity, thus reducing MMΦ' function and even precipitate onto biological membranes
or nucleic acids (due to its poor water solubility), causing injury and compromising MMΦ' integrity.
On the cellular level, BrB acts as an endogenous agonist for a pleotropic transcription factor, aryl hydrocarbon
receptor (AhR), a protein that, based on prior research and our preliminary data, plays essential roles in
supporting MMΦ for their integrity and function during hematoma clearance to enhance brain recovery after ICH.
Our preliminary studies established that intracellularly elevated free BrB in microglia (MΦ), during
erythrophagocytosis, activates AhR to promote transcription of BrB handling proteins, ligandins
[(LGN/glutathione S-transferases), which bind fBrB to increase its cytosol solubility] and multidrug resistance
protein 1 [(Mrp1)14, 15, which mediates efflux of BrB from the intracellular compartment to the extracellular space].
Without fast clearance of intracellularly accumulating fBrB, MΦ are injured and function less efficiently, and
produce large amount of proinflammatory factors that could cause severe brain damage. In addition, we
established that BrB-activated AhR promotes phagocytosis and upregulates the expression of nuclear factor
erythroid 2-related factor 2 (Nrf2), a master regulator of cellular oxidative defense for hematoma detoxification,
and a potential therapeutic target for ICH. Furthermore, we established that AhR activity regulates RelB nuclear
translocation, suggesting that AhR may also interact with RelB to transactivate genes involving inflammation
resolution. Ultimately, using the mouse model of ICH, we found very promising therapeutic benefits of AhR
agonist ITE19-21, alone and even more so in combination with the activator of Nrf2 (sulforaphane, SF), regarding
neurological outcome and hematoma clearance.
Our hypothesis is that after ICH, activation of AhR/RelB in MMΦ during hematoma removal by BrB (or other
non-toxic AhR activators) is vital for preserving MMΦ' survival/phagocytic functions, avoiding self-inflicted
damage, retention of reparative phenotype, ultimately leading to a more efficient MMΦ-mediated hematoma
clearance and repair after ICH. Activation of AhR could be a novel therapeutic target for ICH.
脑出血 (ICH) 后,血肿成分 [红细胞 (RBC)、
小胶质细胞/巨噬细胞 (MMΦ) 的血红蛋白 (Hb) 和血红素] 对于去除/解毒至关重要
血肿、炎症消退和恢复大脑稳态以实现最佳神经功能恢复。
因此,保护 MMΦ 在有毒血肿成分吞噬过程中免受损伤的策略对于
MMΦ清除ICH后血肿的效率。
在吞噬血肿中的 RBC/Hb/血红素后,MMΦ 表达血红素加氧酶 1(HO1;编码为
Hmox1),在 MMΦ 内分解血红素产生大量胆红素 (BrB)。通常 BrB 是
有益且有效的抗氧化剂;然而,当细胞内 BrB 积累到非常高的浓度时,
可能可逆地抑制 HO1 活性,从而降低 MMΦ 的功能,甚至沉淀到生物膜上
或核酸(由于其水溶性差),造成损伤并损害 MMΦ 的完整性。
在细胞水平上,BrB 充当多效性转录因子芳基烃的内源性激动剂
受体(AhR),一种基于先前研究和我们的初步数据的蛋白质,在
支持 MMΦ 在血肿清除过程中的完整性和功能,以增强 ICH 后的大脑恢复。
我们的初步研究表明,在小胶质细胞 (MΦ) 中,细胞内游离 BrB 升高
噬红细胞作用,激活 AhR 促进 BrB 处理蛋白、配体蛋白的转录
[(LGN/谷胱甘肽 S-转移酶),结合 fBrB 以增加其胞质溶解度] 和多药耐药性
蛋白 1 [(Mrp1)14, 15,介导 BrB 从细胞内区室流出到细胞外空间]。
如果不能快速清除细胞内积累的 fBrB,MΦ 就会受到损伤并且功能效率降低,并且
产生大量促炎因子,可能导致严重的脑损伤。此外,我们
确定 BrB 激活的 AhR 促进吞噬作用并上调核因子的表达
红细胞 2 相关因子 2 (Nrf2),血肿解毒细胞氧化防御的主要调节因子,
以及 ICH 的潜在治疗靶点。此外,我们确定 AhR 活性调节 RelB 核
易位,表明 AhR 也可能与 RelB 相互作用,反式激活涉及炎症的基因
解决。最终,通过使用 ICH 小鼠模型,我们发现了 AhR 非常有前景的治疗益处
激动剂 ITE19-21,单独使用,与 Nrf2 激活剂(萝卜硫素,SF)联合使用更是如此,
神经系统结果和血肿清除。
我们的假设是,ICH后,在BrB(或其他药物)清除血肿期间,MMΦ中的AhR/RelB被激活
无毒的 AhR 激活剂)对于保持 MMΦ 的生存/吞噬功能、避免自残至关重要
损伤,保留修复表型,最终导致更有效的 MMΦ 介导的血肿
ICH 后的清除和修复。 AhR 的激活可能成为 ICH 的新治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jaroslaw Aronowski其他文献
Jaroslaw Aronowski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jaroslaw Aronowski', 18)}}的其他基金
Aryl hydrocarbon receptor and bilirubin as therapeutic target for ICH
芳烃受体和胆红素作为脑出血的治疗靶点
- 批准号:
10615880 - 财政年份:2021
- 资助金额:
$ 46.49万 - 项目类别:
Aryl hydrocarbon receptor and bilirubin as therapeutic target for ICH
芳烃受体和胆红素作为脑出血的治疗靶点
- 批准号:
10408850 - 财政年份:2021
- 资助金额:
$ 46.49万 - 项目类别:
Stroke Preclinical Assessment Network (SPAN) – Tacilizumab for treatment of acute ischemic stroke
卒中临床前评估网络 (SPAN) – 他珠单抗治疗急性缺血性卒中
- 批准号:
10214711 - 财政年份:2019
- 资助金额:
$ 46.49万 - 项目类别:
Optimized lactoferrin for treatment of intracerebral hemorrhage
优化乳铁蛋白治疗脑出血
- 批准号:
9016473 - 财政年份:2015
- 资助金额:
$ 46.49万 - 项目类别:
Optimized lactoferrin for treatment of intracerebral hemorrhage
优化乳铁蛋白治疗脑出血
- 批准号:
9248446 - 财政年份:2014
- 资助金额:
$ 46.49万 - 项目类别:
Optimized lactoferrin for treatment of intracerebral hemorrhage
优化乳铁蛋白治疗脑出血
- 批准号:
8831091 - 财政年份:2014
- 资助金额:
$ 46.49万 - 项目类别:
Treatment of secondary injury after ischemic stroke through targeting microglia
通过靶向小胶质细胞治疗缺血性中风后继发性损伤
- 批准号:
8573537 - 财政年份:2013
- 资助金额:
$ 46.49万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 46.49万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 46.49万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 46.49万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 46.49万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 46.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 46.49万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 46.49万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 46.49万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 46.49万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 46.49万 - 项目类别:
Miscellaneous Programs